News & Events NewsPress Releases In the Code Blog In the News Media Kit Press Releases May 07, 2024 Encoded Therapeutics Presents Preclinical Data Across its Gene Therapy Portfolio at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) April 23, 2024 Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) February 26, 2024 Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101 View All Press Releases In the Code Blog June 03, 2024 RARECast podcast: Differentiating Gene Therapies through Regulatory Elements Read Full Article October 24, 2023 Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies Read Full Article October 13, 2022 Building Customized Gene Expression Profiles Read Full Article View All Blog Articles In the News June 13, 2022 Gene therapy targets interneurons to tackle Dravet syndrome Spectrum May 12, 2022 Gene Therapy’s Commercial Manufacturing Issues — With Encoded Therapeutics’ Andy Stober Cell and Gene Podcast August 10, 2021 Activating SCN1A to Treat Dravet Syndrome GeneTherapyLive View All News Stories Media Kit Logo Leadership Photos Kartik Ramamoorthi, Ph.D. Encoded Co-Founder, CEO and Board Member Stephanie Tagliatela Encoded Co-Founder, Chief Scientific Officer and Board Member Salvador Rico, M.D., Ph.D. Encoded Chief Medical Officer Photos Encoded lab coat Encoded Therapeutics headquarters in South San Francisco Scientists in Encoded’s sequencing lab Scientist in Encoded’s lab Scientist in Encoded’s lab Scientist in Encoded’s lab Download Photo Archive Video Footage